Polarized macrophage-derived microvesicles differentially modulate intestinal barrier dysfunction and endoplasmic reticulum stress in ulcerative colitis
Related Experiment Video
Updated: Nov 1, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Chaoyue Liang1, Qasim Khan1, Yanling Wei1
1Department of Gastroenterology, The First Affiliated Hospital of Shihezi University, Shihezi, 832008, China.
Abstract:
Macrophage polarization is critically involved in the initiation and progression of ulcerative colitis (UC); however, whether microvesicles (MVs) released from macrophages with distinct polarization states exert different effects on the intestinal epithelial barrier and endoplasmic reticulum (ER) stress remains unclear. Here, MVs were isolated from M0, M1, and M2 macrophages and evaluated in a dextran sulfate sodium (DSS)-induced mouse colitis model and an inflammatory cytokine-stimulated NCM460 epithelial cell model. M2 macrophage-derived MVs (M2-MVs) mitigated body-weight loss, disease activity, colon shortening, and histopathological injury and partially restored Claudin-1, Occludin, ZO-1, and MUC2 expression. In contrast, M1 macrophage-derived MVs (M1-MVs) tended to aggravate inflammation and barrier disruption. Mechanistically, M2-MVs reduced IL-1β, TNF-α, and IL-6, increased IL-10, and inhibited GRP78, PERK/eIF2α phosphorylation, CHOP, and cleaved caspase-3. Consistent effects were observed in vitro, where M2-MVs restored barrier proteins and reduced ER stress and apoptosis. Moreover, the ER-stress inhibitor 4-phenylbutyric acid attenuated the detrimental effects of M1-MVs, supporting ER stress as an important downstream mechanism. By systematically comparing MVs from M0, M1, and M2 macrophages in parallel, this study reveals a polarization-dependent, bidirectional pattern of macrophage-epithelial communication in experimental colitis and provides preclinical evidence supporting M2-MVs as candidate cell-free effectors for intestinal mucosal repair.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease